Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Change in Cash (2016 - 2025)

Historic Change in Cash for BioCorRx (BICX) over the last 17 years, with Q3 2025 value amounting to $175816.0.

  • BioCorRx's Change in Cash rose 222466.47% to $175816.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $287598.0, marking a year-over-year increase of 28398.15%. This contributed to the annual value of $22811.0 for FY2024, which is 77229.59% up from last year.
  • According to the latest figures from Q3 2025, BioCorRx's Change in Cash is $175816.0, which was up 222466.47% from $87730.0 recorded in Q2 2025.
  • BioCorRx's 5-year Change in Cash high stood at $1.3 million for Q1 2021, and its period low was -$1.2 million during Q2 2021.
  • Moreover, its 5-year median value for Change in Cash was -$6383.0 (2023), whereas its average is -$16019.2.
  • Per our database at Business Quant, BioCorRx's Change in Cash crashed by 189290.21% in 2023 and then skyrocketed by 222466.47% in 2025.
  • Over the past 5 years, BioCorRx's Change in Cash (Quarter) stood at -$659619.0 in 2021, then surged by 100.77% to $5086.0 in 2022, then crashed by 1892.9% to -$91187.0 in 2023, then soared by 196.44% to $87943.0 in 2024, then surged by 99.92% to $175816.0 in 2025.
  • Its Change in Cash stands at $175816.0 for Q3 2025, versus $87730.0 for Q2 2025 and -$63891.0 for Q1 2025.